Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System
In December 2020, the U.S. Food and Drug Administration licensed COVID-19 vaccines for emergency use authorization. We investigated the ocular adverse event reports in patients reported to the Vaccine Adverse Event Reporting System (VAERS) following vaccination against COVID-19. We searched the VAER...
Main Authors: | Cyril N. A. Nyankerh, Akosua K. Boateng, Mary Appah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/6/941 |
Similar Items
-
Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008–2016
by: Penina Haber, et al.
Published: (2018-11-01) -
Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015
by: Elaine R. Miller, et al.
Published: (2018-08-01) -
OAE-based data mining and modeling analysis of adverse events associated with three licensed HPV vaccines
by: Wenrui Zi, et al.
Published: (2022-11-01) -
Lessons learned from annotation of VAERS reports on adverse events following influenza vaccination and related to Guillain-Barré syndrome
by: Madhuri Sankaranarayanapillai, et al.
Published: (2024-01-01) -
Ocular Adverse Events after Inactivated COVID-19 Vaccination in Xiamen
by: Xiuju Chen, et al.
Published: (2022-03-01)